» Articles » PMID: 11011143

Kinetic Basis for the Donor Nucleotide-sugar Specificity of Beta1, 4-N-acetylglucosaminyltransferase III

Overview
Journal J Biochem
Specialty Biochemistry
Date 2000 Sep 30
PMID 11011143
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The kinetic basis of the donor substrate specificity of beta1, 4-N-acetylglucosaminyltransferase III (GnT-III) was investigated using a purified recombinant enzyme. The enzyme also transfers GalNAc and Glc moieties from their respective UDP-sugars to an acceptor at rates of 0.1-0.2% of that for GlcNAc, but Gal is not transferred at a detectable rate. Kinetic analyses revealed that these inefficient transfers, which are associated with the specificity of the enzyme, are due to the much lower V(max) values, whereas the K(m) values for UDP-GalNAc and UDP-Glc differ only slightly from that for UDP-GlcNAc. It was also found that various other nucleotide-Glc derivatives bind to the enzyme with comparable affinities to those of UDP-GlcNAc and UDP-Glc, although the derivatives do not serve as glycosyl donors. Thus, GnT-III does not appear to distinguish UDP-GlcNAc from other structurally similar nucleotide-sugars by specific binding in the ground state. These findings suggest that the specificity of GnT-III toward the nucleotide-sugar is determined during the catalytic process. This type of specificity may be efficient in preventing a possible mistransfer when other nucleotide-sugars are present in excess over the true donor.

Citing Articles

Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.

Hanzawa K, Tanaka-Okamoto M, Murakami H, Suzuki N, Mukai M, Takahashi H PLoS One. 2022; 17(4):e0266927.

PMID: 35413075 PMC: 9004742. DOI: 10.1371/journal.pone.0266927.


UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase.

Ma L, Salas O, Bowler K, Bar-Peled M, Sharon A mBio. 2017; 8(6).

PMID: 29162710 PMC: 5698552. DOI: 10.1128/mBio.01559-17.


Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Raval K, Tao R, White B, de Lange W, Koonce C, Yu J J Biol Chem. 2014; 290(5):3121-36.

PMID: 25488666 PMC: 4317045. DOI: 10.1074/jbc.M114.628628.


Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes.

Oguri S, Yoshida A, Minowa M, Takeuchi M Glycoconj J. 2006; 23(7-8):473-80.

PMID: 17006639 DOI: 10.1007/s10719-006-6216-3.


Dynamic control of oligosaccharide modification in the mammary gland: linking recombinant human erythropoietin functional analysis of transgenic mouse milk-derived hEPO.

Kwon D, Song H, Park J, Lee S, Cho S, Kang S Transgenic Res. 2006; 15(1):37-55.

PMID: 16475009 DOI: 10.1007/s11248-005-3519-2.